Clearpoint Neuro Inc reports results for the quarter ended in September - Earnings Summary

Clearpoint Neuro

10/11/2021 08:06

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly adjusted
loss of 18 cents​​ per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 16
cents per share.
* Revenue rose 30% to $4.57 million from a year ago;  analysts
expected $4.00 million. 
* Clearpoint Neuro Inc's reported EPS for the quarter was a loss
of 18 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Clearpoint Neuro Inc shares had fallen by 2.9% this
quarter and gained 8.5% so far this year.
* The company reported a quarterly loss of $3.98 million.
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $32.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 08:06 a.m.
 ​All figures in US dollars unless otherwise stated